Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William T Hu

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Continuum (Minneapolis, Minn.)|July 20, 2012
Patient management problemWilliam T Hu
The Lancet. Psychiatry|October 8, 2017
No doubts about dementia advocacyWilliam T Hu
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 11, 2023
Lessons Learned in Time-Is Neurodegeneration Still Something Unpredictable?William T Hu
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 10, 2022
Reporting and social construction of race in Alzheimer's disease clinical trialsWilliam T Hu
Current Neurology and Neuroscience Reports|August 12, 2009
TDP-43 and frontotemporal dementiaWilliam T Hu, Murray Grossman
International Review of Psychiatry (Abingdon, England)|April 25, 2013
From frontotemporal lobar degeneration pathology to frontotemporal lobar degeneration biomarkersChadwick M Hales, William T Hu
Journal of Healthcare, Science and the Humanities|September 10, 2025
Racial disparities in COVID-19 deaths in GeorgiaWilliam T Hu, Aimee P Hu
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 28, 2023
Charting the Next Road Map for CSF Biomarkers in Alzheimer's Disease and Related DementiasWilliam T Hu, Ashima Nayyar, Milota Kaluzova
Acta Neuropathologica|October 25, 2013
Alzheimer's disease biomarkers: walk with deliberate haste, don't run blithely on?William T Hu, Leslie M Shaw, John Q Trojanowski
Frontiers in Aging Neuroscience|September 7, 2018
Automation vs. Experience: Measuring Alzheimer's Beta-Amyloid 1-42 Peptide in the CSFAlexander L Kollhoff, Jennifer C Howell, William T Hu
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Continuum (Minneapolis, Minn.)|July 20, 2012
Patient management problemWilliam T Hu
The Lancet. Psychiatry|October 8, 2017
No doubts about dementia advocacyWilliam T Hu
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 11, 2023
Lessons Learned in Time-Is Neurodegeneration Still Something Unpredictable?William T Hu
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 10, 2022
Reporting and social construction of race in Alzheimer's disease clinical trialsWilliam T Hu
Current Neurology and Neuroscience Reports|August 12, 2009
TDP-43 and frontotemporal dementiaWilliam T Hu, Murray Grossman
International Review of Psychiatry (Abingdon, England)|April 25, 2013
From frontotemporal lobar degeneration pathology to frontotemporal lobar degeneration biomarkersChadwick M Hales, William T Hu
Journal of Healthcare, Science and the Humanities|September 10, 2025
Racial disparities in COVID-19 deaths in GeorgiaWilliam T Hu, Aimee P Hu
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 28, 2023
Charting the Next Road Map for CSF Biomarkers in Alzheimer's Disease and Related DementiasWilliam T Hu, Ashima Nayyar, Milota Kaluzova
Acta Neuropathologica|October 25, 2013
Alzheimer's disease biomarkers: walk with deliberate haste, don't run blithely on?William T Hu, Leslie M Shaw, John Q Trojanowski
Frontiers in Aging Neuroscience|September 7, 2018
Automation vs. Experience: Measuring Alzheimer's Beta-Amyloid 1-42 Peptide in the CSFAlexander L Kollhoff, Jennifer C Howell, William T Hu
Pageof 10